Ron P. Schuring

633 total citations
14 papers, 429 citations indexed

About

Ron P. Schuring is a scholar working on Infectious Diseases, Health and Surgery. According to data from OpenAlex, Ron P. Schuring has authored 14 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 4 papers in Health and 3 papers in Surgery. Recurrent topics in Ron P. Schuring's work include SARS-CoV-2 and COVID-19 Research (6 papers), Leprosy Research and Treatment (6 papers) and Tuberculosis Research and Epidemiology (4 papers). Ron P. Schuring is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Leprosy Research and Treatment (6 papers) and Tuberculosis Research and Epidemiology (4 papers). Ron P. Schuring collaborates with scholars based in Switzerland, Netherlands and Japan. Ron P. Schuring's co-authors include Linda Oskam, David Pahan, Jan Hendrik Richardus, F. Johannes Moet, Ralf R. Schumann, Lutz Hamann, William R. Faber, Kyoko Murakami, Mitsuhiro Mori and Frank P. Mockenhaupt and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and PLoS neglected tropical diseases.

In The Last Decade

Ron P. Schuring

12 papers receiving 415 citations

Peers

Ron P. Schuring

EPIDE

SURGE

IMMUN

Maurício Lisboa Nobre Brazil

Maria Araci de Andrade Pontes Brazil

Laarni G. Villahermosa United States

J. M. Pönnighaus Germany

Wakako Goto United States

Nacarid Aránzazu Venezuela

Elsa Rada Venezuela

Elizabeth Race United States

Magilé Fonseca Cuba

Kapil Dev Neupane United Kingdom

Maurício Lisboa Nobre Brazil

Ron P. Schuring

356 ×1.0

176 ×0.8

EPIDE

89 ×0.6

SURGE

30 ×0.4

IMMUN

6 ×0.2

Citations per year, relative to Ron P. Schuring Ron P. Schuring (= 1×) peers Maurício Lisboa Nobre

Countries citing papers authored by Ron P. Schuring

Since Specialization

Citations

This map shows the geographic impact of Ron P. Schuring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron P. Schuring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron P. Schuring more than expected).

Fields of papers citing papers by Ron P. Schuring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron P. Schuring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron P. Schuring. The network helps show where Ron P. Schuring may publish in the future.

Co-authorship network of co-authors of Ron P. Schuring

This figure shows the co-authorship network connecting the top 25 collaborators of Ron P. Schuring. A scholar is included among the top collaborators of Ron P. Schuring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron P. Schuring. Ron P. Schuring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Anugulruengkitt, Suvaporn, Keswadee Lapphra, Kriengsak Limkittikul, et al.. (2025). Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine. Vaccine. 62. 127558–127558.

Murakami, Kyoko, et al.. (2025). One-year follow-up of the immunogenicity and safety of a first and second booster dose of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Final report of a phase 3 open-label trial. Vaccine. 62. 127562–127562.

Murakami, Kyoko, et al.. (2024). One-year follow-up of the immunogenicity and safety of a primary series of the NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Final report of a phase I/II randomized controlled trial. Vaccine. 42(6). 1319–1325. 3 indexed citations

Murakami, Kyoko, et al.. (2023). Immunogenicity and safety of a second heterologous booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Interim analysis report of a phase 3 open-label trial. Vaccine. 42(3). 662–670. 2 indexed citations

Murakami, Kyoko, et al.. (2023). Immunogenicity and safety of a single booster dose of NVX-CoV2373 (TAK-019) in healthy Japanese adults who had previously received a primary series of COVID-19 mRNA vaccine: Primary analysis report of a phase 3 open-label trial. Vaccine. 41(25). 3763–3771. 5 indexed citations

Murakami, Kyoko, et al.. (2022). Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial. Vaccine. 40(24). 3380–3388. 14 indexed citations

Murakami, Kyoko, et al.. (2022). A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report. Vaccine. 40(13). 2044–2052. 12 indexed citations

Schuring, Ron P., Lutz Hamann, William R. Faber, et al.. (2009). Polymorphism N248S in the Human Toll‐Like Receptor 1 Gene Is Related to Leprosy and Leprosy Reactions. The Journal of Infectious Diseases. 199(12). 1816–1819. 80 indexed citations

Schuring, Ron P., Jan Hendrik Richardus, David Pahan, & Linda Oskam. (2009). Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention. Vaccine. 27(50). 7125–7128. 49 indexed citations

10.

Hamann, Lutz, Oliver Kumpf, Ron P. Schuring, et al.. (2009). Low frequency of the TIRAPS180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy. BMC Medical Genetics. 10(1). 65–65. 36 indexed citations

11.

Schuring, Ron P., Jan Hendrik Richardus, Ewout W. Steyerberg, et al.. (2008). Preventing Nerve Function Impairment in Leprosy: Validation and Updating of a Prediction Rule. PLoS neglected tropical diseases. 2(8). e283–e283. 13 indexed citations

12.

Moet, F. Johannes, Ron P. Schuring, David Pahan, Linda Oskam, & Jan Hendrik Richardus. (2008). The Prevalence of Previously Undiagnosed Leprosy in the General Population of Northwest Bangladesh. PLoS neglected tropical diseases. 2(2). e198–e198. 49 indexed citations

13.

Moet, F. Johannes, David Pahan, Ron P. Schuring, Linda Oskam, & Jan Hendrik Richardus. (2006). Physical Distance, Genetic Relationship, Age, and Leprosy Classification Are Independent Risk Factors for Leprosy in Contacts of Patients with Leprosy. The Journal of Infectious Diseases. 193(3). 346–353. 149 indexed citations

14.

Schuring, Ron P., F. Johannes Moet, David Pahan, Jan Hendrik Richardus, & Linda Oskam. (2006). Association between anti-PGL-I IgM and clinical and demographic parameters in leprosy. Leprosy Review. 77(4). 343–355. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact